Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice.

PloS one - 15 Oct 2009

Beghin Anne, Belin Stéphane, Hage-Sleiman Rouba, Hage Sleiman Rouba, Brunet Manquat Stéphanie, Goddard Sophie, Tabone Eric, Jordheim Lars P, Treilleux Isabelle, Poupon Marie-France, Diaz Jean-Jacques, Dumontet Charles

Abstract excerpt

We have previously reported that ADP ribosylation factor like 2 (Arl2), a small GTPase, content influences microtubule dynamics and cell cycle distribution in breast tumor cells, as well as the degree and distribution of phosphorylated P53. Here we show, in two different human breast adenocarcino...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression Regulation, Neoplastic
Share to GTP-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Mice, SCID

Share to Neoplasm Invasiveness

Share to Phosphorylation

Share to Protein Phosphatase 2

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 19829707
DOI: 10.1371/journal.pone.0007478
PMCID: PMC2759505

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19829707-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice.PMID 19829707Read ↗

ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancerSemantic proximity Read ↗

A novel ER–microtubule-binding protein, ERLIN2, stabilizes Cyclin B1 and regulates cell cycle progressionSemantic proximity Read ↗

Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.Semantic proximity Read ↗

Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.Semantic proximity Read ↗

ADP ribosylation factor-like protein 2 (Arl2) regulates the interaction of tubulin-folding cofactor D with native tubulin.Semantic proximity Read ↗

Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migrationSemantic proximity Read ↗

Oncogenic activity of poly (ADP-ribose) glycohydrolaseSemantic proximity Read ↗

The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancerSemantic proximity Read ↗

Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.Semantic proximity Read ↗

Arl2 and Arl3 regulate different microtubule-dependent processes.Semantic proximity Read ↗

AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10‐mediated regulatory pathwaySemantic proximity Read ↗

NDRG2 Expression in Breast Cancer Cells Downregulates PD-L1 Expression and Restores T Cell Proliferation in Tumor-CocultureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.